Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Exploring the link between metabolism and sleep apnea

Official title: Metabolism and Sleep Apnea Treatment

Run by University of Miami · NCT05539716 · Data updated 2026-11-12

This study is testing how sleep apnea affects fat metabolism and whether treatments like PAP therapy and lifestyle changes can improve energy and sugar use in people with this condition.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment100 (estimated)
SponsorUniversity of Miami
Academic / other
Locations1 site (Miami, Florida)
StatusRecruiting
StartedMay 20, 2022
Main results expectedJune 1, 2027
Study endsSeptember 1, 2027
Registry record updatedMarch 23, 2026
Trial IDNCT05539716 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-70 who can provide consent and do not have severe obesity or significant comorbid conditions.

Probably not a fit

Patients with a BMI over 40, diabetes, or other serious medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research investigates the relationship between obstructive sleep apnea (OSA) and fat metabolism abnormalities. The study aims to evaluate how fat is metabolized in individuals with and without OSA, focusing on the substances released by fat tissue and their impact on energy and sugar utilization in the body. Participants will receive interventions including PAP therapy and lifestyle counseling to assess their effects on metabolic processes.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies for patients with obstructive sleep apnea by addressing metabolic dysfunction.

How similar studies have gone: While the specific approach of linking fat metabolism to sleep apnea is novel, related studies have shown promising results in understanding metabolic disorders associated with sleep conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Aim 1 Group:

Inclusion criteria:

* Age between 18-70 years
* Ability to provide consent

Exclusion criteria

* Body Mass Index (BMI) \> 40 kg/m2
* Prevalent myocardial infarction, coronary revascularization, heart failure, and stroke
* Type 1 or Type 2 diabetes mellitus
* Current or prior use of PAP or oral appliance therapy for OSA
* Use of oral corticosteroids
* Unstable medical conditions that may preclude enrollment in the protocol such as: uncontrolled angina and/or congestive heart failure, uncontrolled blood pressure or resistant hypertension, severe chronic obstructive pulmonary disease, cancer, and active psychiatric disease (e.g., major depression)
* Other sleep disorders (e.g., circadian rhythm disorder, self-reported habitual sleep duration \< 6h)
* Use of supplemental oxygen during wakefulness or sleep
* Central sleep apnea, obesity hypoventilation syndrome or Cheyne-Stokes respiration based on the home sleep test
* Resting awake Oxygen Saturation (SpO2) \< 90%

Aim 2 Group:

Inclusion criteria:

* Age between 18-70 years
* Ability to provide consent
* Moderate-to-severe OSA (AHI ≥ 15/h);
* Demonstration of Positive Airway Pressure (PAP) use of \> 4 h/night on 70% of the nights during 1-week run-in period
* Successful completion of all of the procedures for Aim 1.

Exclusion criteria:

* BMI: ≥ 40 kg/m2
* Type 1 or Type 2 diabetes mellitus
* Current use of PAP or oral appliance therapy for OSA
* Commercial driver or report of motor vehicle accident or near-miss due to sleepiness within the 2 previous years
* Epworth sleepiness score of 18 or more
* Use of oral corticosteroids
* Participation in another clinical trial
* Unstable medical conditions that may preclude enrollment in the protocol such as: uncontrolled angina and/or congestive heart failure, uncontrolled blood pressure or resistant hypertension, severe chronic obstructive pulmonary disease, cancer, and active psychiatric disease (e.g., major depression)
* Other sleep disorders (e.g., circadian rhythm disorder, self-reported habitual sleep duration \< 6h)
* Use of supplemental oxygen during wakefulness or sleep
* Central sleep apnea, obesity hypoventilation syndrome or Cheyne-Stokes respiration based on the home sleep test
* Resting awake SpO2 \< 90%

Where it's running

  • University of Miami
    Miami, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Naresh Punjabi, MD — University of Miami
  • Study coordinator: Naresh Punjabi, MD
  • Email: npunjabi@miami.edu
  • Phone: 305-243-3963

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.